CDC updates guidance on COVID-19 boosters
The Centers for Disease Control and Prevention (CDC) has updated their recommendations for vaccine boosters within each age group.
NIH updates guidance on influenza season and COVID-19
The National Institute of Health’s (NIH) COVID-19 Treatment Guidelines Panel has updated their recommendations for the upcoming influenza season. Read the latest recommendations from NIH.
Public comment closed Sept. 28
Summer 2022 public comment was open Aug. 3 through Sept. 28. Read all items and view feedback from the community.
The latest data on organ donation and transplant in the U.S.
Find high-level data on transplants, deceased donors recovered, patients added to the waitlist and patients temporarily moved to inactive waitlist status.
Reminders
Updated COVID-19 Summary of Evidence
- The OPTN Ad Hoc Disease Transmission Advisory Committee completed its quarterly update of the SARS-CoV-2 Summary of Evidence on Aug. 22, 2022. This version includes current information on Omicron sublineages BA.4/BA.5 as well as the most recent literature on SARS-CoV-2 and its effect on transplant.
FDA authorizes updated COVID-19 booster
- The Food and Drug Administration (FDA) has authorized the use of updated Moderna and Pfizer vaccines to protect against the Omicron variant of COVID-19 for use as a single booster dose at least two months following a primary or booster vaccination.
Questions
- For COVID-19 related policy and operational questions, email [email protected]
- For information and updates about the status of in-person vs. virtual OPTN committee meetings, check the OPTN calendar of events.
Patient-friendly information for members to share
Scan this QR code to find COVID-19 resources for patients at TransplantLiving.org including:
- Frequently asked questions
- Vaccine and treatment updates
- Webinars
- Spanish-language resources
